Arkolith/Insider Trading/ELVN/Form 4

Kunkel Lori Anne

DirectorEnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Jun 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$345K
Net Open-Market Flow
-$345K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2026Sell(S)8K$34.28$267K54K
Jun 5, 2026Sell(S)2K$35.36$66K52K
Jun 5, 2026Sell(S)354$35.82$13K52K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001536368-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML